| Bid Price | 1.50p | High Price | 1.90p |
|---|
| Ask Price | 1.80p | Low Price | 1.50p |
|---|
| Open Price | 1.70p | Spread | 16.67% |
|---|
| Prev Close | 1.70p | Volume | 470,814 |
|---|
Roquefort Therapeutics PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Aug 4, 2025 | 1.70 | 1.90 | 1.50 | 1.65 | 470,814 |
| Aug 1, 2025 | 1.75 | 1.65 | 1.51 | 1.70 | 908,049 |
| Jul 31, 2025 | 1.75 | 1.90 | 1.60 | 1.75 | 1,036,716 |
| Jul 30, 2025 | 1.75 | 1.74 | 1.60 | 1.75 | 2,006,462 |
| Jul 29, 2025 | 1.80 | 1.82 | 1.65 | 1.75 | 1,721,562 |
Roquefort Therapeutics PLC Information
| Name | Roquefort Therapeutics PLC | Index | |
|---|
| ISIN | GB00BMDQ2T15 | Epic | ROQ |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | SSQ3 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 50,000 | Trading Status | Closed |
|---|
| Shares in Issue | 157.44 m | Prev Close | 1.70p |
|---|
| PE Ratio | | Market Cap | £2.60 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | £-0.00 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.068014 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 0.625186 | Quick Ratio | 0.625186 |
|---|
Roquefort Therapeutics PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 07/07/25 | BUY | Stephen West | CH | 2,400,000 @ £0.02 | £36,000.00 |
| 30/06/25 | BUY | Simon Sinclair | NED | 72,507 @ £0.01 | £993.00 |
| 04/02/25 | BUY | Stephen West | CH | 400,000 @ £0.03 | £10,280.00 |
| 04/02/25 | BUY | Trevor Reginald | RES | 191,059 @ £0.03 | £4,968.00 |
| 04/12/24 | TIN | Darrin Disley | NED | 9,146 @ £0.00 | £0.00 |
| 04/12/24 | TIN | Martin Evans | RES | 2,690 @ £0.00 | £0.00 |
| 04/12/24 | TIN | Trevor Reginald | RES | 34,432 @ £0.00 | £0.00 |
| 02/08/23 | BUY | Darrin Disley | NED | 269,935 @ £0.07 | £19,840.00 |
| 12/07/23 | BUY | Stephen West | CH | 15,730 @ £0.06 | £983.00 |
| 12/07/23 | BUY | Stephen West | CH | 143,390 @ £0.06 | £8,948.00 |
Roquefort Therapeutics PLC News
